Skip to content
CED Clinic
Contact Us Book Consultation GLP-1 Care
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
  • Facebook
  • X
  • Email
  • Instagram
  • YouTube
  • Substack
  • Dr Caplan’s Book
CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
Subscribe
Close

Search

Exclusive
Michigan civic building representing state cannabis product-safety oversight
August 23, 2026
Michigan Recalls Infused Drinks Over THC Potency Concerns
cannabis maple rosemary candied walnuts finished recipe styled as the emotional anchor with warm editorial food photography
August 23, 2026
Cannabis Maple Rosemary Candied Walnuts Recipe
Study Reveals Cannabis, Cocaine, and Amphetamines Significantly Increase Stroke Risk ...
August 23, 2026
Study Reveals Cannabis, Cocaine, and Amphetamines Significantly Increase Stroke Risk …
cbd gummies for kids with autism adhd add: A Parent's Real-World Guide to Safety ...
August 23, 2026
cbd gummies for kids with autism adhd add: A Parent’s Real-World Guide to Safety …
H5O0
August 23, 2026
H5O0
Study Provides Insight Into How To Boost Cannabinoid And Terpene Production
August 23, 2026
Study Provides Insight Into How To Boost Cannabinoid And Terpene Production
Cannabis not 'safer' for younger people, linked to early psychosis - 1News
August 23, 2026
Cannabis not ‘safer’ for younger people, linked to early psychosis – 1News
a large group of white objects
August 23, 2026
Low-Dose THC Mints: A Comprehensive Guide to Their Benefits and Risks
Digital Game Reduces Adolescent Depression | RCT in Cannabis-Inclusive Teens | digital behavioral health game adolescent depression
August 23, 2026
A School-Based Digital Game Modestly Reduced Adolescent Depression: What Clinicians Treating Cannabis-Using Teens Should Know
Lisbon cityscape representing Portugal's regulated medical cannabis sector
August 23, 2026
Portugal Medical Cannabis Exports Top 66 Tonnes in Six Months
Terpenes and cannabinoids are both part of the medical cannabis conversation, but they are ...
August 23, 2026
Terpenes and cannabinoids are both part of the medical cannabis conversation, but they are …
#anandamidegreen | substack https://t.co/y1dyW7Rzq5
August 23, 2026
#anandamidegreen | substack https://t.co/y1dyW7Rzq5
2:1 CBD THC Gummies: Benefits, Effects, and Elevate Reviews of Viral CBD to THC Ratio Products
August 23, 2026
2:1 CBD THC Gummies: Benefits, Effects, and Elevate Reviews of Viral CBD to THC Ratio Products
Multimodal examination of the acute effects of cannabis on subjective and physiological ...
August 23, 2026
Multimodal examination of the acute effects of cannabis on subjective and physiological …
Understanding Terpenes And Their Role In Cannabis
August 23, 2026
Understanding Terpenes And Their Role In Cannabis
Feds Award $6.5M Grant to Support Developing Cannabis Withdrawal Treatment
August 23, 2026
Feds Award $6.5M Grant to Support Developing Cannabis Withdrawal Treatment
Argument for legalising cannabis after concern over psychoactive substances in vapes
August 23, 2026
Argument for legalising cannabis after concern over psychoactive substances in vapes
THE NEW SCIENCE OF CANNABIS AND SLEEP | The Beacon Herald
August 23, 2026
THE NEW SCIENCE OF CANNABIS AND SLEEP | The Beacon Herald
Penn State College of Medicine hosts national gathering of medicinal plant researchers
August 23, 2026
Penn State College of Medicine hosts national gathering of medicinal plant researchers
Medical Marijuana for Epilepsy and Seizures in Texas (2026)
August 23, 2026
Medical Marijuana for Epilepsy and Seizures in Texas (2026)
Endocannabinoid Biology in Health & Disease | Nephi Stella | Episode 305 - Mind & Matter
August 22, 2026
Endocannabinoid Biology in Health & Disease | Nephi Stella | Episode 305 – Mind & Matter
Study Finds CBDA May Reduce Neuroinflammation and Improve Brain Insulin Signaling
August 22, 2026
Study Finds CBDA May Reduce Neuroinflammation and Improve Brain Insulin Signaling
New UMSOP Graduate Certificate in Medical Cannabis Clinical Science
August 22, 2026
New UMSOP Graduate Certificate in Medical Cannabis Clinical Science
Comparative efficacy of non-pharmacological interventions for individuals with cannabis use disorder
August 22, 2026
Comparative efficacy of non-pharmacological interventions for individuals with cannabis use disorder
NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for ...
August 22, 2026
NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for …
cannabis cinnamon mouth spray finished recipe styled as the emotional anchor with warm editorial food photography
August 22, 2026
Cannabis Cinnamon Mouth Spray Recipe
woman in black tank top holding white textile
August 22, 2026
Endocannabinoid-Glucocorticoid Crosstalk in Pain Resolution
Daily Cannabis News Brief for 8/21/2026
August 22, 2026
Daily Cannabis News Brief for 8/21/2026
New UMSOP Graduate Certificate in Medical Cannabis Clinical Science
August 22, 2026
New UMSOP Graduate Certificate in Medical Cannabis Clinical Science
Canada's health ministry this week announced a $24 million investment in research ...
August 22, 2026
Canada’s health ministry this week announced a $24 million investment in research …
Study Finds CBDA May Reduce Neuroinflammation and Improve Brain Insulin Signaling
August 22, 2026
Study Finds CBDA May Reduce Neuroinflammation and Improve Brain Insulin Signaling
Home/Cannabis News/Michigan Recalls Infused Drinks Over THC Potency Concerns
Michigan civic building representing state cannabis product-safety oversight
Cannabis News

Michigan Recalls Infused Drinks Over THC Potency Concerns

By Benjamin Caplan, MD
13 Min Read
Comments Off on Michigan Recalls Infused Drinks Over THC Potency Concerns

 

CED Clinical Relevance #87 High Product Safety and Patient Relevance A state regulator warning identifies specific cannabis beverages that may exceed THC limits, have variable potency or poor homogeneity, and carry an inaccurate serving-count declaration.
Clinical Insight | CED Clinic
Michigan’s Cannabis Regulatory Agency and a Kalamazoo processor are recalling certain 200 mg marijuana-infused drinks after testing indicated that affected products may exceed allowable THC concentration limits. The company is also investigating potency variability and homogeneity, and the regulator says the products carry an inaccurate serving-count declaration. No associated adverse health effects had been reported to the company as of August 18. Consumers should identify the exact product and METRC package tag, return or safely dispose of recalled products, and avoid tasting or estimating a dose from an affected container.
MichiganCannabis RecallTHC PotencyInfused DrinksPatient Safety
Audience Michigan cannabis consumers, patients, families, clinicians, dispensaries, caregivers, and public-health readers.
Primary Topic Michigan’s August 2026 voluntary recall of certain 200 mg marijuana-infused drinks over potency, homogeneity, and serving-count concerns.
Source Read the current Michigan recall report

Table of Contents

  • Michigan Recalls Infused Drinks Over THC Potency Concerns
    • How to Read the Michigan Beverage Recall
      • Four distinctions that matter
    • Michigan’s Cannabis Beverage Recall Through Eight Practical Lenses
        • Match the Exact Package Tag
        • Treat Product Details as Exposure Data
        • Prevent Secondary Exposure While Checking
        • Make Recall Communication Specific
        • Find the Failure, Not Just the Inventory
        • Connect Traceability With Follow-Up
        • Avoid Both Panic and False Reassurance
        • Measure Recall Reach and Consumer Understanding
    • Frequently Asked Questions
  • Newsletter Signup Form
      • Read next
      • Related

Michigan Recalls Infused Drinks Over THC Potency Concerns

Talk to Dr. Caplan

This issue affects real patients. Dr. Caplan can help yours.

30,000+ patients treated. Appointments in Massachusetts and via telemedicine.

Book a consultation →GLP-1 + cannabis program
BC

Dr. Benjamin Caplan, MD

Board-certified Family Medicine

20+ years in cannabis medicine. CMO, CED Clinic. Author, Penguin Random House. Principal Investigator in multiple studies.

Full bio →

Related reading

  • Conditions A–Z →
  • Cannabis & anxiety →
  • Cannabis & sleep →
  • Cannabinoid profiles →

Wherever you are

Dr. Caplan offers consultations for complex conditions and wellness needs. Patients from across the US and internationally are welcome.

Book a consultation →

Michigan has issued a public-health advisory for certain 200 mg marijuana-infused drinks that may exceed THC limits and may not be uniform throughout the container.

What This Study Teaches Us
The recall is product and package specific. It covers nine named flavors and many METRC package tags, with affected inventory distributed through licensed retailers in Muskegon, Lansing, Battle Creek, and Kalamazoo.
Why This Matters
A beverage that contains more THC than allowed, distributes THC unevenly, or misstates its serving count can undermine dose estimation. That matters especially when a person expects each measured portion to deliver a consistent amount.
Study Snapshot
Regulatory notice Michigan Cannabis Regulatory Agency public-health and safety advisory
Announcement date August 20, 2026
Manufacturer Season 3, LLC, Kalamazoo
Affected product type Nuggz Nectar Infused Drink 200mg marijuana-infused edible products
Named flavors Blue Razz, Cherry Bomb, Grape, Green Apple, Hulk Juice, Lemonade, Mango, Tropical Punch, and Watermelon Splash
Reason Possible excess THC concentration, potency variability, homogeneity concerns, and inaccurate serving-count declaration
Locations named Licensed retailers in Muskegon, Lansing, Battle Creek, and Kalamazoo
Adverse events None reported to the company as of August 18, 2026
Consumer action Check the recall list and METRC tag, then return or safely dispose of recalled product
Evidence type Official regulator recall notice and package inventory
Clinical evidence None; this is a product-safety action
Clinical Bottom Line
Check the exact product and METRC package tag. Do not consume an affected drink to test its strength, and do not assume one portion represents the rest of a container when homogeneity is under investigation.
Opening News Brief

On August 20, Michigan’s Cannabis Regulatory Agency announced a voluntary recall of certain Nuggz Nectar 200 mg marijuana-infused drinks made by Season 3, LLC, of Kalamazoo. Testing indicated that affected products may exceed allowable THC concentration limits. Read the official advisory.

The company is also investigating potency variability and homogeneity, and the affected products have an inaccurate serving-count declaration. The regulator lists nine flavors and many specific METRC package tags in its recall inventory. No associated adverse effects had been reported to the company as of August 18.

For Patients and Families

Keep the original container and compare its METRC package tag with the regulator list. If it matches, return it to the retailer or dispose of it safely as directed. Do not taste the drink to decide whether it seems affected.

Store all infused beverages locked away from children and separate from ordinary drinks. A colorful flavor name or familiar beverage format does not make a high-THC product suitable for casual or shared use.

For Clinicians

When a patient reports an unexpectedly strong or inconsistent response, ask for the product name, package tag, labeled total THC, stated servings, amount consumed, timing, co-use, symptoms, and disposition of the remaining product.

Clinical severity, not the existence of a recall alone, should guide care. Michigan directs consumers with adverse reactions to contact a healthcare provider and allows reporting to the CRA by form or telephone.

How This Fits the Bigger Picture

Cannabis beverages require more than an accurate total-potency number. The formulation should distribute cannabinoids consistently, the label should define servings clearly, and consumers should understand the total amount in the container.

Michigan requires new or revised marijuana-infused beverages to undergo agency approval. The recall shows why formulation review, production controls, testing, traceability, and prompt retail removal all matter after a product reaches the market.

What This Does Not Show

The advisory does not publish the measured THC concentration for each package or state that every listed unit has the same deviation. It does not identify a final root cause.

No adverse effects associated with the recalled products had been reported to the company as of August 18. That is not proof of zero exposure or zero risk, and it should not be rewritten as evidence of confirmed injuries.

Key Clinical Caveats

Oral THC effects can be delayed and prolonged. Risk varies with the amount consumed, prior exposure, food intake, metabolism, co-use with alcohol or sedatives, and cardiovascular or psychiatric vulnerability.

Seek urgent help for severe confusion, chest symptoms, psychosis, loss of consciousness, trouble breathing, persistent vomiting, or suspected child exposure. Do not drive or perform hazardous work while impaired.

Where It Deserves Skepticism

The state notice is authoritative about the recall. It is incomplete for estimating clinical risk because it does not provide package-level laboratory results, exposure counts, or a completed causal investigation.

Brand-wide alarm and market-wide reassurance are both unsupported. The useful unit of action is the exact product and package tag identified by the regulator.

Policy and Advocacy Angle

Recall notices should be searchable by brand, flavor, package tag, retail location, date, and consumer action. Clear notices reduce the chance that patients overlook a product or discard unrelated inventory.

Follow-up reporting should describe measured deviations, root cause, recovered inventory, corrective action, and whether repeat testing demonstrates improved consistency, while protecting confidential information where legally required.

How Strong Is This Evidence?
Strong for the recall scope, stated reasons, named flavors, distribution cities, package tags, and absence of reported adverse events through August 18 because those details come from Michigan’s regulator. Limited for the degree of excess potency, the number of consumers exposed, and clinical effects because those data were not published in the notice.
Where This Paper Deserves Skepticism
The advisory establishes a legitimate product-safety action, but it does not publish measured THC values for each package or describe the investigation’s final cause. Headlines should not convert a precautionary recall into proof that every container was dangerously potent or that all regulated cannabis beverages are unreliable.
What This Paper Does Not Show
The recall does not show that every product from the company is affected, that every listed container contains the same error, that anyone was harmed, or that 200 mg on the package represents a suitable dose. It also does not establish contamination or explain whether the problem arose during formulation, mixing, testing, packaging, or labeling.
How This Fits With the Broader Clinical Conversation

Cannabis beverage safety depends on accurate total potency, a clear serving size, uniform distribution within the container, stable formulation, and consumer understanding of delayed and variable effects.

Traceable package tags allow a broad brand-level warning to become a specific product check. That distinction helps remove affected inventory without treating unrelated products as recalled.

Dr. Caplan’s Take

This recall is a reminder that a familiar package and a printed number are useful only when the formulation is consistent and the serving declaration is accurate. If homogeneity is uncertain, a measured sip may not reliably predict the amount in another portion of the same container.

The safest response is product-specific. Keep the package, compare its METRC tag with the regulator list, return or dispose of affected products, and report unexpected reactions. Patients should not compensate for uncertainty by shaking, diluting, tasting, or trying to calculate a corrective dose.

What a Careful Reader Should Take Away
Michigan consumers should check the regulator’s package-tag list and return or safely dispose of affected drinks rather than trying to estimate their potency.
Evidence Interpretation Guide

How to Read the Michigan Beverage Recall

This is a package-specific product-safety action, not a clinical study.

Four distinctions keep the notice useful and proportionate.

Four distinctions that matter

Brand name versus package tag
The regulator provides specific METRC tags, so consumers should verify the exact container rather than infer from the brand alone.

Total potency versus homogeneity
A container can have an inaccurate total and may also distribute THC unevenly from one portion to another.

Recall versus confirmed injury
A recall removes a potential hazard. It does not by itself prove that a consumer was harmed.

No reports versus no risk
No associated adverse events had been reported through August 18, but incomplete reporting cannot establish zero exposure or risk.

The Safety Question
Can the regulator and manufacturer show that the cause was corrected and later batches meet potency, homogeneity, and labeling requirements?
The Patient Question
Does my exact package tag appear on the recall list, and did I experience an unexpected reaction?
The Bottom Line
Use the package-tag list, follow the return or disposal instruction, and report adverse reactions.
CED Perspective Lens

Michigan’s Cannabis Beverage Recall Through Eight Practical Lenses

Potency, mixing, labeling, traceability, and clinical response each require a different question

Lens Overview
The recall supports distinct lessons for consumers, clinicians, caregivers, retailers, producers, regulators, skeptical readers, and public-health monitoring without assuming facts that the investigation has not established.

Match the Exact Package Tag

The immediate question is whether the container in hand appears on Michigan’s recall list. The brand name and flavor narrow the search, but the METRC package tag provides the most specific match. A person should keep the original container long enough to verify that identifier and follow the return or disposal instruction if it is listed.

Do not taste, shake, dilute, or divide an affected drink in an attempt to make it usable. The stated concerns include both potency and homogeneity, so home adjustments cannot establish how much THC is present in a portion. The notice does not mean that every product from the manufacturer is recalled.

Lens takeaway
Use the regulator’s package-tag list and avoid improvised attempts to salvage or redose an affected drink.

Treat Product Details as Exposure Data

For a clinician, the key question is what the patient consumed and what happened afterward. Record the product, flavor, package tag, labeled total THC, stated serving count, estimated amount, time of use, other substances, symptom onset, and symptom course. Those details help separate a product concern from other clinical explanations.

The recall does not provide a package-level dose reconstruction, so clinicians should avoid claiming an exact exposure from the label or notice. Care should follow the patient’s symptoms and vulnerabilities. Unexpected reactions can be reported to the Michigan CRA after immediate medical needs are addressed.

Lens takeaway
A careful exposure history is more clinically useful than assuming the recalled label reveals the dose consumed.

Prevent Secondary Exposure While Checking

Caregivers face two linked questions: whether the product is recalled and how to secure it until it is returned or discarded. Infused drinks can resemble ordinary beverages, and multiple flavor names increase the chance of confusion in a shared refrigerator or pantry. Keep the container closed, separate, and inaccessible to children or other household members.

If someone may already have consumed it, preserve the packaging and note the time, estimated amount, symptoms, medicines, and co-use. The absence of adverse-event reports through August 18 does not predict an individual response. Serious symptoms or suspected child exposure need prompt professional guidance.

Lens takeaway
Secure the container first, preserve identifying details, and respond to symptoms rather than waiting for certainty about potency.

Make Recall Communication Specific

Retailers must determine which package tags entered inventory, remove affected units, and communicate clearly with purchasers. A useful notice names the product, flavor, package identifier, consumer action, and contact route without implying that unrelated products are unsafe. Accurate point-of-sale records can make outreach faster and more precise.

The practical boundary is that a retailer cannot diagnose exposure or guarantee the content of an affected container. Staff should direct consumers to the official recall information and appropriate medical care for adverse reactions. Completion should be documented so remaining inventory does not return to sale.

Lens takeaway
Retail recall work should be traceable, package specific, and clear about where consumers can obtain medical or regulatory help.

Find the Failure, Not Just the Inventory

The producer’s central question is whether the problem arose in formulation, mixing, sampling, testing, packaging, serving calculations, or more than one step. Potency variability and homogeneity are related but distinct. A correct average across a batch would not guarantee that cannabinoids are evenly distributed within each container or serving.

Corrective action should therefore extend beyond retrieving inventory. It may require a documented root-cause analysis, validated mixing and sampling procedures, label review, repeat testing, and evidence that later batches remain consistent. The public notice does not yet identify a final cause, so assigning one would be premature.

Lens takeaway
A defensible correction must show why the error occurred and how later production will prevent the same failure.

Connect Traceability With Follow-Up

Michigan’s package-tag inventory turns a broad warning into a traceable product action. The next regulatory question is how completely affected units are recovered and whether the manufacturer demonstrates corrected potency, homogeneity, and serving declarations. Publishing clear updates would help consumers know when the investigation is resolved.

Regulators must balance transparency with the limits of an active investigation. Early notices may appropriately omit uncertain causal claims, but later reports can still provide aggregate measured deviations, recovered inventory, corrective actions, and repeat-testing results. Those details show whether recall authority improves product safety in practice.

Lens takeaway
The recall becomes more informative when regulators publish the verified cause, corrective action, and evidence of sustained compliance.

Avoid Both Panic and False Reassurance

A cautious reader should accept what the official notice establishes: certain products are recalled because testing raised potency concerns, with additional investigation of variability, homogeneity, and serving counts. The notice does not establish that every listed container has the same deviation or that every cannabis beverage in Michigan is unreliable.

It is equally unwarranted to dismiss the action because no associated adverse events had been reported through August 18. Passive reports can be incomplete, and product controls are intended to prevent harm before a case count accumulates. The sound response is specific verification and proportionate caution.

Lens takeaway
Take the package-specific recall seriously without converting limited regulator findings into market-wide claims or guaranteed clinical harm.

Measure Recall Reach and Consumer Understanding

Public-health value depends on whether affected consumers see the notice, identify their product correctly, and return or safely discard it. Useful measures include purchaser outreach, inventory recovery, website access, adverse-reaction reports, and the proportion of contacted consumers who understand the serving and homogeneity concerns.

Surveillance also needs a denominator. Raw complaint counts cannot reveal risk without knowing how many units were distributed or consumed, and zero reports do not prove zero events. Privacy-protective follow-up can clarify whether the recall reached patients and whether communication reduced continued exposure.

Lens takeaway
Evaluate the recall by its reach, inventory recovery, consumer comprehension, and verified safety outcomes, not publicity alone.

Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan

Want to discuss this topic with other patients and caregivers? Join the forum discussion

CED Clinic logo
Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance
Leave a Message Metabolic Care Medical Consulting Cannabis Care
Dr. Benjamin Caplan
Share this Evidence Watch
X LinkedIn BlueSky Instagram Substack RSS
Source: Kalamazoo business voluntarily recalling marijuana-infused drink over THC potency concerns
Related Reading at CED Clinic
Continue exploring the evidence
Massachusetts THC Potency Audit Flags 13 Cannabis Flower Products

A related regulator action involving potency-label accuracy, product holds, and the limits of targeted testing.

Compare the potency oversight
How to Make Edibles at Home: A Safer Beginner’s Guide

Practical context on dose awareness, delayed effects, labeling, and safe storage for ingestible cannabis.

Review edible safety principles
Understanding the Colorado Best Dabs Pesticide Contamination Recall

CED guidance on checking a product-specific recall and separating verified findings from broader assumptions.

Read the recall context

Frequently Asked Questions

Which Michigan cannabis drinks are being recalled?

The recall covers certain Nuggz Nectar Infused Drink 200mg products in nine named flavors and specific METRC package tags listed by Michigan’s Cannabis Regulatory Agency.

Why were the infused drinks recalled?

Testing indicated that affected products may exceed allowable THC concentration limits. The company is also investigating potency variability and homogeneity, and the products have an inaccurate serving-count declaration.

Which flavors are named in the recall?

Blue Razz, Cherry Bomb, Grape, Green Apple, Hulk Juice, Lemonade, Mango, Tropical Punch, and Watermelon Splash are named.

How can a consumer check an exact product?

Compare the METRC package tag on the original container with the package-tag inventory on the Michigan CRA recall page.

What should consumers do with a recalled drink?

Michigan advises consumers to return recalled products to the purchase location or dispose of them safely.

Were adverse health effects reported?

No associated adverse health effects or other adverse events had been reported to the company as of August 18, 2026.

What does a homogeneity concern mean?

It means THC may not be distributed consistently throughout a product, so one portion may not reliably represent another portion.

Should someone taste a recalled drink to judge its strength?

No. Tasting cannot verify potency or uniformity and may create avoidable exposure.

What should someone do after an unexpected reaction?

Contact a healthcare provider based on symptom severity. Michigan also accepts adverse-reaction reports through the CRA form or by telephone.

Does this recall affect every Michigan cannabis beverage?

No. It applies to the products and package tags identified by the regulator, not every beverage or every product from the manufacturer.

 

  • Newsletter Signup Form

    Enter your email address to subscribe to our newsletter.
  • Should be Empty:

Read next

Study Reveals Cannabis, Cocaine, and Amphetamines Significantly Increase Stroke Risk …

Related

Tags:

cannabis beverage potencyMichigan cannabisMichigan THC drink recallNuggz Nectar recallpatient safetyProduct Recall
Author

Benjamin Caplan, MD

Follow Me
Other Articles
cannabis maple rosemary candied walnuts finished recipe styled as the emotional anchor with warm editorial food photography
Previous

Cannabis Maple Rosemary Candied Walnuts Recipe

Book Now Intake Form
Dr. Benjamin Caplan, MD Learn About Dr. Caplan
Copyright 2026 — CED Clinic. All rights reserved.

Questions about this topic?

Talk to Dr. Caplan →
CED Clinic
CED Clinic Home
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU